Tri-vylibra Kit
Product Images NDC 50102-233

The label appears to be for an item with the barcode number 0180501050215. The label has spaces for the day of the week and can be peeled and placed on an item. The label also has color-coding options of white and light blue. There is a code at the bottom that may indicate a quantity of 1000000.*

This text provides a list of studies comparing the risk of certain health outcomes between women who have used combined oral contraceptives (COC) and those who have never used them, as well as studies comparing current COC use to never-use. The studies are presented with their corresponding effect estimate (odds ratio, relative risk or hazard ratio) and the confidence interval. Some studies show a slightly lower risk (OR/RR < 1.0) and others a slightly higher risk (OR/RR > 1.0) for certain outcomes among COC users, but none of the estimates are statistically significant. However, one study comparing current use to never-use did find a statistically significant increased risk. The text is likely intended for use in a medical or research setting.*

This is a description of different methods of birth control and their effectiveness rates. It starts by describing the different rates of pregnancies per 100 women in one year, ranging from fewer than 1 to 85 or more. The text then lists different methods of birth control including implants, injections, intrauterine devices, sterilization, birth control pills, skin patch, vaginal ring with hormones, condoms, diaphragm, no sex during the most fertile days of the monthly cycle, spermicide, and withdrawal.*

This is a description of a prescription drug called Tri-VyLibra manufactured by Afaxys Aurobindo Pharma Limited. Each package contains 26 tablets of different colors which work to prevent pregnancy. It should be noted that this product, like other oral contraceptives, does not protect against sexually transmitted diseases.*